tiprankstipranks
Dr. Reddy’s Q4 and FY24 Financial Results Due
PremiumCompany AnnouncementsDr. Reddy’s Q4 and FY24 Financial Results Due
7d ago
Dr. Reddy’s Faces Tax Demand; Plans Appeal
PremiumCompany Announcements
Dr. Reddy’s Faces Tax Demand; Plans Appeal
8d ago
Dr. Reddy’s Divests Venezuelan Subsidiary Stake
PremiumCompany Announcements
Dr. Reddy’s Divests Venezuelan Subsidiary Stake
11d ago
Dr. Reddy’s Launches Novel Shock Treatment in India
PremiumCompany AnnouncementsDr. Reddy’s Launches Novel Shock Treatment in India
1M ago
Dr. Reddy’s Upcoming Board Meeting & Trading Window Closure
PremiumCompany Announcements
Dr. Reddy’s Upcoming Board Meeting & Trading Window Closure
1M ago
Dr. Reddy’s, Pharmazz enter licensing agreement to market Centhaquine
PremiumThe Fly
Dr. Reddy’s, Pharmazz enter licensing agreement to market Centhaquine
1M ago
Dr. Reddy’s downgraded to Underperform from Buy at Jefferies
PremiumThe FlyDr. Reddy’s downgraded to Underperform from Buy at Jefferies
4M ago
Journey Medical submits NDA to FDA for DFD-29
PremiumThe Fly
Journey Medical submits NDA to FDA for DFD-29
4M ago
Coya Therapeutics’ CEO gives update, sufficient cash for COYA 302 Phase 2 trial
PremiumThe Fly
Coya Therapeutics’ CEO gives update, sufficient cash for COYA 302 Phase 2 trial
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100